These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 17671202)

  • 1. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
    Park KJ; Lee SH; Kim TI; Lee HW; Lee CH; Kim EH; Jang JY; Choi KS; Kwon MH; Kim YS
    Cancer Res; 2007 Aug; 67(15):7327-34. PubMed ID: 17671202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim.
    Xia S; Li Y; Rosen EM; Laterra J
    Mol Cancer Res; 2007 Aug; 5(8):783-92. PubMed ID: 17699104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation.
    Zhu H; Guo W; Zhang L; Wu S; Teraishi F; Davis JJ; Dong F; Fang B
    Cancer Biol Ther; 2005 Jul; 4(7):781-6. PubMed ID: 16082182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isogambogenic acid induces apoptosis-independent autophagic cell death in human non-small-cell lung carcinoma cells.
    Yang J; Zhou Y; Cheng X; Fan Y; He S; Li S; Ye H; Xie C; Wu W; Li C; Pei H; Li L; Wei Z; Peng A; Wei Y; Li W; Chen L
    Sci Rep; 2015 Jan; 5():7697. PubMed ID: 25571970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
    Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
    Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
    Izeradjene K; Douglas L; Delaney AB; Houghton JA
    Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis.
    Clancy L; Mruk K; Archer K; Woelfel M; Mongkolsapaya J; Screaton G; Lenardo MJ; Chan FK
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18099-104. PubMed ID: 16319225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
    Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT
    Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis.
    Jin Z; El-Deiry WS
    Mol Cell Biol; 2006 Nov; 26(21):8136-48. PubMed ID: 16940186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.
    Lin Y; Devin A; Cook A; Keane MM; Kelliher M; Lipkowitz S; Liu ZG
    Mol Cell Biol; 2000 Sep; 20(18):6638-45. PubMed ID: 10958661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
    Wenger T; Mattern J; Penzel R; Gassler N; Haas TL; Sprick MR; Walczak H; Krammer PH; Debatin KM; Herr I
    Cell Death Differ; 2006 Oct; 13(10):1740-51. PubMed ID: 16470224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
    Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
    BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
    Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM
    J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L; Fang B
    Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
    Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
    Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.